What to Expect in 2026?
Returning to London, the 7th Gene Therapy Analytical Development Summit Europe convenes analytical leaders who are shaping how potency, quality, and safety are defined for next-generation gene therapies across Europe.
Across three focused days, this year’s programme delivers:
- Technical case studies and expert-led discussions on potency assurance, method validation, and regulatory readiness
- Interactive forums and workshops exploring fit-for-purpose analytical strategies for later-stage development
- Practical insights into designing phase-appropriate analytical packages that support confident regulatory and development decisions
Attendees will leave with clear strategies to:
- Improve assay reproducibility and robustness
- Contextualise complex analytical outputs
- Align analytical development with process, clinical, and QC realities
- Future-proof potency and QC approaches under cost and data constraints
Don't Miss:
Regulatory Scenario Workshop: Green Light or Red Flag? A Regulator-led Review of a Hypothetical Gene Therapy QC Strategy
Led by MeiraGTx and the MHRA
A rare opportunity to experience a live, agency-featured stress test where a hypothetical gene therapy QC strategy is reviewed in real time to reveal what might trigger a green light versus red flag and how to future-proof your own submissions
Tackling the ‘Mother of All Assays’
Learn from experts at Regeneron, Orchard Therapeutics, and Complement Therapeutics, as they unpack their strategies to help you reduce assay variability, increase confidence, and streamline development timelines of novel gene therapies
Enhancing Patient Safety with Next-Generation Analytics
Join experts from UCB and iBET Bio for deep dives into high-sensitivity impurity profiling, mass photometry, and advanced stability analytics, to uncover the hidden risks before they impact the potency, safety, or clinical performance of your gene therapy asset in development
Six Hours of Case-Study-Led Workshops You Can Apply Immediately
Go beyond presentations with immersive, discussion-driven workshops covering early-phase analytical strategy and QC-ready analytics under real-world constraints, including paediatric and patient-specific programmes, designed to help your teams make better, more informed analytical decisions sooner
Reconnect, Collaborate & Expand Your Network
Engage in 6+ hours of structured networking, including roundtable discussions and speed networking, designed to spark collaboration and build lasting partnerships across biopharma, academic, and regulatory peers
Fresh perspectives from New & Returning Gene Therapy Leaders
Gain refreshed insights from new and returning speakers across Europe’s Gene Therapy Landscape, including Orchard Therapeutics, AAvantgarde, PureSpring Therapeutics, Complement Therapeutics and UniQure as they share updated strategies shaped by the latest technical and regulatory learnings
Explore the Agenda
- 16+ expert speakers from the likes of AAVantgarde, UCB, PureSpring Therapeutics, Regeneron, and UniQure
- 3 days of cutting-edge analytical and QC content addressing the toughest challenges in potency assurance, product characterisation, and analytical readiness across gene therapy platforms
- 6 hours of immersive, case-study led sessions tackling both earlier stage analytical development and later stage QC challenges
- Regulatory-led sessions featuring voices from the Medicines and Healthcare products Regulatory Agency (MHRA) with pharmacopeial insights
Attending Companies Include
Explore the Agenda
Preview regulator-led discussions on analytical strategy, alongside hands-on workshops exploring real-world approaches to assay challenges, QC readiness, and potency assurance.
Partner With Us
Position yourself as the go-to solution provider by showcasing your expertise and value to a room full of biopharma KOLs.
Join Biopharma Experts
Engage with analytical development, QC, CMC, and regulatory leaders through structured networking, roundtables, and small-group discussions to accelerate your gene therapy pipelines.